Records containing: Multiple Sclerosis

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2013-02-06
  A Pilot Study to Assess the Relative Safety and Immunology Effects of Low Dose Versus High Dose Cholecalciferol Supplementation in Patients With Multiple Sclerosis
• CLINICAL_TRIALS study record update · 2013-01-29
  TOP MS is a Study of Multiple Sclerosis Disease Management in Collaboration With Specialty Pharmacies
• CLINICAL_TRIALS study record update · 2013-01-29
  The Effects of Vestibular Rehabilitation on MS-related Fatigue and Upright Postural Control: a Randomized Controlled Trial
• CLINICAL_TRIALS study record update · 2013-01-23
  Developing Neuroprotection and Repair Strategies in MS: Phase IIa Randomized, Controlled Trial of Minocycline in Acute Optic Neuritis (ON)
• CLINICAL_TRIALS study record update · 2013-01-16
  Pilot Study of CBT and Self-hypnosis Training for Pain in Persons With Multiple Sclerosis
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2013-01-15
  Randomised Double Blind Placebo-controlled Trial of Vitamine D Supplement in Multiple Sclerosis
• CLINICAL_TRIALS study record update · 2013-01-04
  A 24-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose Finding, Safety, Tolerability, and Efficacy Study of the Human Anti-IL-12 Antibody ABT-874 in Subjects With Multiple Sclerosis With a 24-Week Double-Blind, Active Extension Phase
• CLINICAL_TRIALS study record update · 2012-12-31
  Long-term Extension of the Multinational, Double-blind, Placebo Controlled Studies PDY6045 and PDY6046 to Document the Safety of Teriflunomide When Added to Treatment With Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis With Relapses
• CLINICAL_TRIALS study record update · 2012-12-20
  Role of Vitamin D on the Relapse Rate of Multiple Sclerosis
• CLINICAL_TRIALS study record update · 2012-12-07
  The Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) in Patients With Post Traumatic Stress Disorder in Multiple Sclerosis. A Randomized Controlled Trial.
• CLINICAL_TRIALS study record update · 2012-12-04
  A Double-blind, Randomized, Placebo Controlled, Multicenter, Dose-finding Trial of Ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) Patients
• CLINICAL_TRIALS study record update · 2012-12-03
  Study Impact, on Clinical Outcomes, Quality of Life and Costs of 2 Therapeutic Strategy (Monthly Natalizumab Versus Mitoxantrone Then Immunomodulator) at 3 Years of Follow-up for Aggressive Remitting Multiple Sclerosis
• CLINICAL_TRIALS study record update · 2012-12-03
  A Monocentric, Randomized, Controlled Trial to Test the Efficacy of Interferon-beta in the Treatment of Disseminated Encephalomyelitis (ED)-Associated and Primary Intermediate Uveitis in Comparison to Standard Treatment (TEAM)
• CLINICAL_TRIALS study record update · 2012-11-30
  REsPonse to Interferon-Alpha in InterfeRon-β Neutralizing Antibody Positive Multiple Sclerosis Patients
• CLINICAL_TRIALS study record update · 2012-11-22
  A Long-term Follow up of Patients Enrolled in the Pivotal Study of Betaseron® (Interferon Beta 1b) in Relapsing-remitting Multiple Sclerosis
• CLINICAL_TRIALS study record update · 2012-11-19
  A Randomized, Single-Blind, Crossover Study in Healthy Volunteers to Demonstrate the Bioequivalence of Interferon Beta-1a Manufactured by Two Different Processes
• CLINICAL_TRIALS study record update · 2012-11-15
  Combination Therapy Using Mycophenolate Mofetil (CellCept) and Human Interferon beta1a (Rebif) in Early Treatment of Multiple Sclerosis
• CLINICAL_TRIALS study record update · 2012-11-12
  MRI Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri
• CLINICAL_TRIALS study record update · 2012-11-06
  A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Design Study to Evaluate the Efficacy and Safety of Teriflunomide in Reducing the Frequency of Relapses and Delaying the Accumulation of Physical Disability in Subjects With Multiple Sclerosis With Relapses
• CLINICAL_TRIALS study record update · 2012-11-06
  A Pilot Trial to Study the Pharmacokinetics of Oral Lipoic Acid (LA) and Immunological Effects of LA in Multiple Sclerosis
• CLINICAL_TRIALS study record update · 2012-11-06
  A Multi-center, Randomized, Parallel-group, Rater-blinded Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis Plus a Long Term Extension Period
• CLINICAL_TRIALS study record update · 2012-11-02
  A Randomized, Multinational, Double-blind, Placebo-controlled, Parallel-group Design Pilot Study to Estimate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamic Effects of Teriflunomide for 24 Weeks When Added to Treatment With Glatiramer Acetate in Subjects With Multiple Sclerosis
• CLINICAL_TRIALS study record update · 2012-11-02
  A Randomized, Multinational, Double-Blind, Placebo-Controlled, Parallel-Group Design Pilot Study to Estimate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamic Effects of Teriflunomide for 24 Weeks When Added to Treatment With Interferon-beta in Subjects With Multiple Sclerosis.
• CLINICAL_TRIALS study record update · 2012-10-30
  Double-blind, Randomized, Placebo-controlled, Parallel-group, Multicenter Study Evaluating the Safety, Tolerability and Effect on MRI Lesion Parameters of FTY720 vs Placebo in Patients With Relapsing Multiple Sclerosis Including 18 Month Extension Phase
• CLINICAL_TRIALS study record update · 2012-10-26
  A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia